- Home
- QNCX vs EQS Comparison
QNCX vs EQS Comparison
Compare QNCX & EQS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | QNCX | EQS |
|---|---|---|
| Founded | 2012 | 1991 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Finance Companies |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 19.9M | 19.6M |
| IPO Year | 2019 | 1995 |
Fundamental Metrics
Financial Performance| Metric | QNCX | EQS |
|---|---|---|
| Price | $0.99 | $1.24 |
| Analyst Decision | Hold | |
| Analyst Count | 2 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 466.1K | 18.8K |
| Earning Date | 04-10-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 2.88 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $0.34 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.08 | $1.07 |
| 52 Week High | $4.55 | $2.49 |
Technical Indicators
Market Signals| Indicator | QNCX | EQS |
|---|---|---|
| Relative Strength Index (RSI) | 47.33 | 42.98 |
| Support Level | $0.88 | $1.10 |
| Resistance Level | $0.98 | $2.03 |
| Average True Range (ATR) | 0.07 | 0.07 |
| MACD | 0.00 | -0.01 |
| Stochastic Oscillator | 62.13 | 50.00 |
Price Performance
Historical ComparisonAbout QNCX Quince Therapeutics Inc.
Quince Therapeutics Inc is a late-stage biotechnology company dedicated to unlocking the power of a patient's own biology for the treatment of rare diseases. Its proprietary AIDE technology is an inventive drug/device combination platform that uses an automated process to encapsulate a drug into a patient's own red blood cells. Its Phase 3 asset, eDSP, leverages the AIDE technology to encapsulate DSP into a patient's own red blood cells, and is targeted to treat a rare pediatric neurodegenerative disease, A-T.
About EQS Equus Total Return Inc.
Equus Total Return Inc is a United States-based closed-end management investment company. The company invests mainly in companies pursuing growth either through acquisition or organically, leveraged buyouts, management buyouts, and recapitalizations of existing businesses or special situations, and achieves capital appreciation by making investments in equity and equity-oriented securities issued by privately-owned companies or smaller public companies in transactions.